1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP
    Dismiss Notice

Venlafaxine

Discussion in 'Drug Articles' started by DmTryp, Jan 20, 2013.

  1. DmTryp

    DmTryp Titanium Member

    Reputation Points:
    174
    Joined:
    Dec 29, 2010
    Messages:
    122
    Female from U.S.A.
    Venlafaxine, brand name Effexor, belongs to a class of antidepressants known as serotonin norephinephrine reuptake inhibitors (SNRIs). It is most commonly prescribed for major depression and/or anxiety disorders.

    [h="1"]Introduction to Venlafaxine[/h]
    [imgr=white]https://drugs-forum.com/forum/attachment.php?attachmentid=21419&d=1310508168[/imgr]Venlafaxine, brand name Effexor, is a phenylethylamine that belongs to a class of antidepressants known as serotonin norephinephrine reuptake inhibitors (SNRIs). It works by blocking the reuptake transporters for norepinephrine and serotonin, allowing the neurotransmitters to remain in the synaptic cleft for an extended period of time and continue to stimulate the post-synaptic neuron. Venlafaxine also appears to weakly inhibit dopamine reuptake in the frontal cortex of the brain. It is used in the treatment of Major Depressive Disorder, Generalized Anxiety Disorder, and Panic Disorder. It should never be taken in combination with other serotogenic or amphetamine-like drugs.

    [h="1"]Using Venlafaxine[/h]

    [h="2"]Ways of Administration[/h]
    Venlafaxine is prescribed for oral administration.

    Recommended beginning daily dose of venlafaxine is 75mg, sometimes divided between two to three doses taken throughout the day, depending on your needs. Dosage may be increased in 75mg increments every four days. Extremely depressed patients may take up to 375mg/day in individual doses.

    At low doses (<150 mg/day), it acts only on serotonergic transmission. At moderate doses (>150 mg/day), it acts on serotonergic and noradrenergic systems, whereas at high doses (>300 mg/day), it also affects dopaminergic neurotransmission.

    [H="3"]Physical effects of Venlafaxine[/H]
    Venlafaxine is effective at treating the physical symptoms associated with depression, anxiety and panic disorders in some patients. It has also been found to be effective in the treatment of neuropathy and migraines.

    Commonly reported physical side effects of venlafaxine include:
    -asthenia
    -sweating
    -nausea
    -constipation
    -anorexia
    -vomiting
    -somnolence
    -dry mouth
    -dizziness
    -tremor
    -blurred vision
    -abnormal ejaculation/orgasm and impotence in men

    [H="3"]Psychological effects of Velafaxine[/H]
    Venlafaxine is effective at relieving the psychological symptoms associated with depression, anxiety and panic disorders in some patients.

    Commonly reported adverse psychological side effects of venlafaxine include:
    -nervousness
    -anxiety

    [h="2"]Combinations with Venlafaxine[/h]
    Venlafaxine should also not be combined with other serotogenic drugs to include MAOIs, SSRIs, SNRIs, psychedelic tryptamines (DMT, LSD, etc.), psychedelic phenylethylamines (MDMA, mescaline, etc.), tramadol, and dextromethorphan (DXM) as it may result in a serious and potential lethal interaction known as serotonin syndrome. Venlafaxine therapy should be terminated at least seven days prior to the administration of another serotogenic drug.

    Use of venlafaxine with other amphetamine-like drugs is discouraged by the manufacturer.

    [h="2"]Different Uses for Velafaxine[/h]
    Venlafaxine is used for the treatment of:

    -Major Depressive Disorder
    -Generalized Anxiety Disorder
    -Panic Disorder

    [h="1"]Pharmacology of Venlafaxine[/h]
    Venlafaxine works by blocking the reuptake transporters for norepinephrine and serotonin, allowing the neurotransmitters to remain in the synaptic cleft for an extended period of time and continue to stimulate the post-synaptic neuron. Venlafaxine also appears to weakly inhibit dopamine reuptake in the frontal cortex of the brain at higher doses of 300mg+

    Venlafaxine is metabolized by the liver with O-desmethylvenlafaxine as the major active metabolite. It is eliminated by the kidneys with approximately 87% of dose recovered in the urine after 48 hours.

    Venlafaxine half-life is approximately 5 hours with O-desmethylvenlafaxine, venlafaxine's active metabolite, having a half-life of approximately 11 hours.

    [h="1"]Chemistry of Venlafaxine[/h]
    Column 1 Column 2
    0 Systematic (IUPAC) name: 1-[2-Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol
    1 Synonyms: (±)-1-[[alpha]-[(dimethylamino)-methyl]-p-methoxybenzyl]cyclohexanol, N,N-dimethyl-2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethylamine, venlafexine; Wy-45030, Effexor (hydrochloride); Wy-45655 ((+)-form hydrochloride); Wy-45651 ((-)-form hydrochloride)
    2 Molecular Formula: C[sub]17[/sub]H[sub]27[/sub]NO[sub]2[/sub]
    3 Molar mass: 277.41 g/mol, 313.87 g/mol (hydrochloride)
    4 CAS Registry Number: 93413-69-5, 99300-78-4 (hydrochloride)
    5 Melting Point: 215-217°C (hydrochloride), 102-104°C ((+)/(-)-form), 240-240.5°C ((+)/(-)-form hydrochloride)
    6 Boiling Point: no data
    7 Flash Point: no data
    8 Solubility: hydrochloride solubility in water 572 mg/mL
    9 Additionnal data: hydrochloride partition coefficient (octanol/water) 0.43
    10 Notes: Hydrochloride white to off-white crystalline solid from methanol/ethyl acetate; (+)/(-)-form crystals from ethyl acetate; (+)/(-)-form hydrochloride crystals from methanol/ether
    [1]

    [h="1"]The Dangers of Venlafaxine[/h]

    [H="3"]Venlafaxine Overdose[/H]
    Overdose on venlafaxine commonly occurs in conjunction with other drugs. Symptoms of overdose include tachycardia, somnolence, coma, mydriasis, seizures, vomiting, EKG changes, ventricular tachycardia, bradycardia, hypotension, rhabdomyolysis, vertigo, liver necrosis, serotonin syndrome, and death . The potential for fatal overdose with venlafaxine is lower than with tricyclic antidepressants but higher than SSRIs.

    [H="3"]Reported deaths[/H]

    [H="2"]Mental health risks[/H]
    Some users of venlafaxine may experience a worsening of depressive symptoms leading to suicidal ideation.

    Anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, and mania, have been reported with the use of venlafaxine. Screening for bipolar disorder should be completed prior to venlafaxine administration to minimize the potential of these symptoms appearing.

    [H="3"]Venlafaxine Addiction[/H]

    [H="4"]Physical Addiction of Venlafaxine[/H]
    Adverse physical reactions that have occurred with the withdrawal of venlafaxine include:

    -Somnolence
    -Insomnia
    -Dizziness
    -Dry mouth
    -Gastrointestinal
    -Nausea
    -Urogenital
    -Abnormal ejaculation or impotence in men
    -Headache
    -Asthenia
    -Sweating

    [H="4"]Mental Addiction of Venlafaxine[/H]
    Common adverse psychological reactions to venlafaxine withdrawal include:

    -Anxiety
    -Nervousness

    [h="1"]Producing/Growing Venlafaxine[/h]

    [h="1"]Forms of Venlafaxine[/h]
    Venlafaxine is prescribed in capsules or pressed tablets of 25mg, 37.5mg, 50mg, 75mg or 100mg. Extended release version comes in 37.5mg, 75mg, 150mg and 225mg capsules.

    [h="1"]Legal Status of Venlafaxine[/h]

    [h="2"]United Nations[/h]

    [H="2"]Australia [/H]

    [H="2"]Canada[/H]

    [h="2"]EU[/h]

    [H="3"]Germany[/H]

    [H="3"]UK[/H]

    [H="2"]New Zealand[/H]

    [h="2"]USA[/h]
    Venlafaxine is available for prescription in the United States

    [h="1"]History of Venlafaxine[/h]
    Wyeth Pharmaceuticals synthesized Venlafaxine in the early 1980s but it was not approved by the FDA until early 1994. The first formulation was immediate release, with an extended release approved by 1997.

    [H="2"]Popularity of Venlafaxine over time[/H]
    [insights]Venlafaxine[/insights]

    [h="1"]More Venlafaxine Sections[/h]

    [h="1"]The Latest VenlafaxineThreads[/h]

    [showthreads=10]<insert forum ID of the drugs forum>[/showthreads]

    [cat]Antidepressants[/cat]
    [CAT]Partial SSRI[/CAT]
    [CAT]Partial SNRI[/CAT]


    [h="1"]References[/h]
    [REFLIST][/REFLIST]
    [1]Merck Index, fifteenth edition (2013)

    Read more: https://drugs-forum.com/forum/sho...#ixzz2IrcFKtFP
     
  2. source

    source Palladium Member

    Reputation Points:
    2,364
    Joined:
    Apr 24, 2010
    Messages:
    1,270
    Female from england
    I'm going through this and correcting the spelling of Venlafaxine, but I cannot seem to change the titles of each section which are also unfortunately spelt wrong.
    Any ideas?

    Also added the effects of Venlafaxine at different dosage levels as Venlafaxine does effect dopaminergic neurotransmission at doses above 300mg.
     
    Last edited: Mar 1, 2013
  3. source

    source Palladium Member

    Reputation Points:
    2,364
    Joined:
    Apr 24, 2010
    Messages:
    1,270
    Female from england
    Ignore that, found out and have now edited the titles to each section now so that they are correct.